| Detected | Trial | Change |
|---|---|---|
| 2026-07-31 | NCT06486883 Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive… |
Trial sites expanded: 72 -> 79 locations |
| 2026-07-28 | NCT06604858 Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative… |
Trial completed |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06382948 | Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer… | Advanced Breast Cancer | Recruiting |
| Phase 2 | |||
| NCT06315010 | REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain… | NSCLC | Recruiting |
| NCT05708235 | A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in… | Breast Cancer | Recruiting |
| NCT06180356 | Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic… | Ovarian Cancer | Recruiting |
| NCT07195227 | Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer | Hormon Receptor Positive Breast Cancer | Recruiting |
| NCT06486883 | Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive… | Advanced Breast Cancer | Recruiting |
| NCT03161353 | Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET… | Breast Cancer | Active, Not Recruiting |
| NCT07178938 | Platform Trial Assessing Uptake, Safety and Efficacy of Theranostic Agents in Solid… | Solid Tumors | Not Yet Recruiting |
| NCT07367178 | Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and… | Breast Cancer | Not Yet Recruiting |
| NCT05810870 | PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in… | Breast Cancer | Active, Not Recruiting |
| NCT04733118 | Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in… | Early Breast Cancer | Active, Not Recruiting |
| NCT06172127 | PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent… | HER2-positive Breast Cancer | Active, Not Recruiting |
| NCT06048718 | T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases | Breast Cancer | Active, Not Recruiting |
| NCT07619066 | A Phase II Study of Zongertinib Plus Fulvestrant in Participants With… | Advanced Breast Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06612203 | Clinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or… | Advanced Breast Cancer | Active, Not Recruiting |
| NCT07460986 | A PHASE IB/II STUDY TO EVALUATE SAFETY AND EFFICACY OF BEXMARILIMAB IN COMBINATION WITH… | Sarcoma of Soft Tissue | Not Yet Recruiting |
| NCT07494448 | Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive… | HER 2 Positive Advanced Breast Cancer | Not Yet Recruiting |
| Not specified | |||
| NCT07515950 | A COMPREHENSIVE BIOMARKER EVALUATION IN BILIARY TRACT CANCER | Biliary Tract Cancer (BTC) | Not Yet Recruiting |